DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares
DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares
Read moreWed, 23rd Sep 2020 16:05
DIRECTOR DEALINGS: Oncimmune Non-Exec Cheung To Sells 195,000 Shares
Read moreUK TRADING UPDATE SUMMARY: Triple Point Social Ups Credit Facility
Read moreUK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink Covid
Read more(Sharecast News) - Oncimmune has signed a commercial contract to supply its 'EarlyCDT Lung' blood test to NHS Norfolk & Waveney Clinical Commissioning Group, it announced on Monday.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus
Read more(Sharecast News) - Immunodiagnostics group Oncimmune has signed a new master service agreement with Augmenta Bioworks, it announced on Wednesday, to profile patient plasma samples and characterise therapeutic candidates discovered through Augmenta's 'SingleCyte' and 'DeepGrid' discovery platforms.
Read moreIN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb
Read moreUK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot
Read moreIN BRIEF: Oncimmune In Covid Antibody Profiling Deal With Cedars-Sinai
Read moreUK TRADING UPDATE SUMMARY: Petra Strikes Deal With South African Union
Read more(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the award of funding from UK Research and Innovation's (UKRI) 'Ideas to Address Covid-19' programme on Tuesday.
Read moreUK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges
Read moreIN BRIEF: Oncimmune Notes Publication Of Study Assessing EarlyCDT Lung
Read more